Tag - DPLO

Markets

WB ups Diplomat Pharmacy to market perform

William Blair upgraded Diplomat Pharmacy (NYSE:DPLO) to “market perform” from “underperform” after UnitedHealth Group’s (NYSE:UNH) OptumRx agreed to acquire Diplomat for $4 a share. Shares of Diplomat were quoted at $3...

December 9, 2019

Markets

Analysts downgrade Diplomat Pharmacy on 10-K filing delay

Analysts for William Blair and SVB Leerink downgraded Diplomat Pharmacy (NYSE:DPLO) after the company delayed reporting fourth-quarter results and filing its 10-K. The stock fell $7.59, or 56%, to $5.87 in heavier than...

February 25, 2019

Tag - DPLO

WB ups Diplomat Pharmacy to market perform

Analysts downgrade Diplomat Pharmacy on 10-K filing delay

General

More